July 1, 2011

FDA approves new drug to treat C diff

By: OR Manager

The Food and Drug Administration in May 2011 approved the first new drug in 25 years to treat diarrhea caused by Clostridium difficile, a pathogen that one study suggests may have surpassed methicillin-resistant Staphylococcus aureus as the leading hospital-acquired infection, according to the New York Times.

Welcome to OR Manager, your source of information and insight into the clinical and business management of the surgical suite. This article is only available to OR Manager subscribers. To read this article, and gain access to all OR Manager resources, please log in below:


Not a subscriber? That’s OK, subscribe today! OR Manager offers all-access subscriptions at an affordable rate. With your subscription – or your team’s group subscription – you’ll receive access to all that OR Manager has to offer, including our monthly issues, CE credit opportunities, job postings, and discounts to our industry-leading conferences.

Explore Subscription Options

Please contact our Customer Service Team if you are unable to log in at clientservices@accessintel.com or 1-888-707-5814.

Get OR Manager Updates

Sign Up Now
Latest Issue of OR Manager
December 2022
Video Spotlight
Live chat by BoldChat